Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

U.S. hotel offers personalized menus for children with food allergies

Traveling and dining with a young child with food allergies or special dietary needs can be a nightmare as most restaurants and hotels are not sensitive to this epidemic affecting more than three million children - one in 17 for those under age 3 - in the U.S. Lake Arrowhead Resort and Spa now offers personalized menus for guests' children on restricted diets to make them feel special, not different.

31 Mar 2010

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).

30 Mar 2010

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.

30 Mar 2010

Preclinical study of DAS181 for treatment and prevention of ILI published

NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.

30 Mar 2010

Rite Aid, AAAAI team up to offer guides to allergy sufferers

Rite Aid and the American Academy of Allergy, Asthma & Immunology are again teaming up this spring to help allergy sufferers with free allergy guides available now in nearly 4,800 Rite Aid stores nationwide and online at www.riteaid.com.

30 Mar 2010

Conference on the actions of Vitamin D on human health

An important conference on the actions of Vitamin D on human health is being hosted by Barts and The London Medical School and the MRC Asthma UK Centre in Allergic Mechanisms of Asthma.

30 Mar 2010

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.

29 Mar 2010

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.

29 Mar 2010

Rigel Pharmaceuticals, AstraZeneca license agreement: Waiting period under Antitrust Improvements Act expires

Rigel Pharmaceuticals, Inc. today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 relating to the license agreement between Rigel and AstraZeneca, the effectiveness of which was contingent on the expiration of the waiting period.

29 Mar 2010

APP adds eClinicalWorks' EMR system to CI Program

In its continuing efforts to enhance patient outcomes and create efficiency in a challenging economic and regulatory climate, Advocate Physician Partners, has added the power of an electronic medical record system to its award-winning Clinical Integration Program. APP, the largest network of independent physicians in the Midwest, is partnering with eClinicalWorks® in one of the biggest EMR implementations in the country.

29 Mar 2010

Minority children in the U.S. face pervasive gap in quality and extent of health care

Minority children in the U.S. face a pervasive gap in the quality and extent of health care received compared to Caucasians, according to a report from the American Academy of Pediatrics written by a UT Southwestern Medical Center physician.

29 Mar 2010

Infrafrontier project expands to include six new partners

Helmholtz Zentrum M-nchen today announced that the Infrafrontier project, funded by the European Union, has been expanded to include six partners from Canada, the Czech Republic, Austria, France and Italy. The new partners will join the effort of the other 22 members of Infrafrontier in building up an international research infrastructure to improve open access to high-quality mouse models.

27 Mar 2010

APHA petitioned EPA to adopt protective standards to safeguard public health from ground-level ozone

The American Public Health Association this week petitioned the U.S. Environmental Protection Agency to adopt stronger, more protective standards to safeguard the health of the public from ground-level ozone.

27 Mar 2010

New report urges government to ban smoking in cars to limit children's exposure to passive smoke

A new report released by the Tobacco Advisory Group of the Royal College of Physicians urges the government to ban smoking in cars and other public vehicles to limit children's exposure to passive smoke.

26 Mar 2010

Animal study shows chymase inhibitors could advance treatments for high BP and heart failure

Millions of patients with high blood pressure and heart failure take a class of drugs known as ACE (angiotensin-converting enzyme) inhibitors. These drugs prevent the body from processing angiotensin II, a hormone that constricts blood vessels.

26 Mar 2010

Natural chemicals from blackcurrants may reduce lung inflammation in allergy-induced asthma

A preliminary study by New Zealand company Plant & Food Research shows that natural chemicals from blackcurrants may help breathing in some types of asthma.

26 Mar 2010

Lack of good health care curtails academic performance: Study

"Educationally relevant health disparities" are key drivers of the achievement gap, "but they are largely overlooked," said Charles Basch, the Richard March Hoe Professor of Health Education at Teachers College, Columbia University.

25 Mar 2010

MediciNova reports net loss of $5.9 million for 2009 fourth quarter

MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced financial results for the fourth quarter and full year ended December 31, 2009.

25 Mar 2010

300,000 extra GP visits for children due to passive smoking - time to make cars and homes smoke free

Doctors have urged an immediate review of the anti-smoking laws in light of such alarming facts. They want a ban on smoking in public places and cars.

25 Mar 2010

Researchers explore ethnic differences in asthma incidence

A study of UK schoolchildren has revealed that Black Africans, Indians and Bangladeshis have a similar or lower prevalence of asthma than White children, while Black Caribbean and Mixed Black Caribbean/White boys are more likely to have asthma.

25 Mar 2010

Asthma News and Research

Further Reading

U.S. hotel offers personalized menus for children with food allergies

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Preclinical study of DAS181 for treatment and prevention of ILI published

Rite Aid, AAAAI team up to offer guides to allergy sufferers

Conference on the actions of Vitamin D on human health

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Rigel Pharmaceuticals, AstraZeneca license agreement: Waiting period under Antitrust Improvements Act expires

APP adds eClinicalWorks' EMR system to CI Program

Minority children in the U.S. face pervasive gap in quality and extent of health care

Infrafrontier project expands to include six new partners

APHA petitioned EPA to adopt protective standards to safeguard public health from ground-level ozone

New report urges government to ban smoking in cars to limit children's exposure to passive smoke

Animal study shows chymase inhibitors could advance treatments for high BP and heart failure

Natural chemicals from blackcurrants may reduce lung inflammation in allergy-induced asthma

Lack of good health care curtails academic performance: Study

MediciNova reports net loss of $5.9 million for 2009 fourth quarter

300,000 extra GP visits for children due to passive smoking - time to make cars and homes smoke free

Researchers explore ethnic differences in asthma incidence

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News